NL Diagnóstica

What NL Diagnóstica does

NL Diagnóstica is a privately held Brazilian diagnostic solutions manufacturer and distributor headquartered in São Paulo, operating for over 30 years in the in vitro diagnostics market. The company serves clinical laboratories, hospitals, clinics, and pharmacies throughout Brazil with a multi-category product portfolio spanning capillary and gel-based electrophoresis systems, proprietary parasitology devices, ELISA immunoassays, platelet aggregation analyzers, point-of-care coagulation systems, and an extensive rapid diagnostics line covering infectious diseases, arboviruses, cardiac markers, and COVID-19.

The company manufactures two patented product lines in-house — the V8 automated 8-channel capillary electrophoresis system and the Coproplus/Coproplus Ultra parasitology systems featuring proprietary double sealed filtration technology. For the remainder of its portfolio, NL Diagnóstica operates as the exclusive Brazilian distributor for internationally recognized diagnostic brands including Helena Laboratories, Helena Biosciences, Meridian Bioscience, GenScript, Cellex, Viramed, Helix, Corgenix, and Alltest. Its go-to-market is sales-led, combining a direct commercial team with multi-channel customer engagement via WhatsApp, email, and dedicated technical and scientific support lines, alongside an own e-commerce platform for A1cNow self-test kits and pharmacy distribution. The company holds BSI ISO 13485 certification, Authorized Economic Operator (OEA) status, and ANVISA registrations across its product range.

Name

NL Diagnóstica

Legal name

NL Diagnóstica

Website

https://nldiagnostica.com.br

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

11–50 employees

Short description

NL Diagnóstica is a Brazilian diagnostic solutions manufacturer and exclusive distributor serving laboratories, hospitals, clinics, and pharmacies across Brazil with proprietary electrophoresis and parasitology systems alongside global brand diagnostic products.

Ownership category

akta.pro rank

Product category

In-Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)

akta.pro secondary industries

Hematology & Coagulation Diagnostics (HLAHAAAB), Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)

Keywords

• In-vitro diagnostics
• Electrophoresis systems
• Parasitology diagnostics
• Point-of-care coagulation
• Rapid diagnostic tests

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Diagnostic Equipment Sales: Sale of diagnostic equipment including V8 capillary electrophoresis, SPIFE agarose gel electrophoresis, QuickScan densitometry, AggRAM platelet aggregometer, and point-of-care coagulation systems (Cascade POC, ABRAZO, Actalyke Mini). Equipment sold with accompanying reagents and consumables.
2. Diagnostic Reagents and Consumables: Recurring revenue from proprietary reagents, test kits, and consumables for electrophoresis, coagulation, ELISA, rapid tests, and parasitology. Includes Coproplus and Coproplus Ultra systems, ELISA kits for hormones and infectious diseases, and rapid test devices.
3. A1cNow Hemoglobin Testing Kits: Sale of A1cNow test kits in 4-test (self-test) and 20-test (professional use) configurations. Each kit includes a meter and test cartridges. Product distributed via pharmacies and medical professionals.
4. Rapid Tests: Sale of rapid diagnostic tests including infectious diseases (Streptococcus, Syphilis, Chlamydia), arboviruses (Dengue, Zika, Chikungunya), cardiac markers (Troponin, D-Dimer), pregnancy (HCG), and COVID-19 tests.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

NL Diagnóstica manufactures and distributes in-vitro diagnostic equipment and reagents for clinical laboratories, hospitals, and clinics in Brazil. The company produces its own Coproplus and Coproplus Ultra parasitology systems and acts as exclusive Brazilian distributor for global diagnostic brands including Helena Laboratories, Helena Biosciences, Meridian Bioscience, Corgenix, GenScript, Viramed, Cellex, Helix, and Alltest. The portfolio spans capillary and gel electrophoresis, platelet aggregation, point-of-care hemostasis, ELISA immunoassays, rapid diagnostic tests, and COVID-19 solutions.

Product overview

NL Diagnóstica is a Brazilian diagnostic company with over 30 years of experience, headquartered in São Paulo, distributing and manufacturing medical diagnostic products. The company operates a multi-category portfolio comprising its own manufactured Coproplus Ultra parasitology system; V8 Capillary Electrophoresis and SPIFE/QuickScan electrophoresis automation platform; a comprehensive ELISA kit line; AggRAM and PlateletWORKS platelet aggregation systems; Point of Care coagulation devices (Actalyke Mini, Cascade POC, Cascade ABRAZO); A1cNow glycated hemoglobin rapid test; and an extensive rapid tests portfolio covering infectious diseases, arboviruses, gastrointestinal disorders, pregnancy, respiratory conditions, parasites, cardiac markers, tumor markers, and drug abuse. COVID-19 solutions include rapid antigen tests (Helix), rapid antibody tests (Cellex), saliva-based tests, ViraChip serological profiling, and cPass neutralizing antibody detection. The company distributes internationally recognized brands including Helena Laboratories, Helena Biosciences, Meridian Bioscience, and Corgenix, all certified under ISO 13485 quality management system.

Differentiator

Problem solved

Functional benefit

Brands

• Coproplus: Parasitological system for collection, transport and analysis of intestinal parasites in fecal specimens
• Coproplus Ultra

Products and services

• Coproplus Ultra Parasitology System

Quantifiable outcome

• Cellex qSARS-CoV-2 IgG/IgM Rapid Test: 93.8% sensitivity, 96% specificity
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Nine partnerships are on record, tiered core.

• Helena LaboratoriescoreTechnology or IntegrationExclusive distribution partnership for Helena Laboratories electrophoresis, coagulation, and platelet aggregation equipment and reagents in Brazil. Products include V8 Capillary Electrophoresis, SPIFE agarose gel systems, QuickScan densitometry, AggRAM platelet aggregometer, and point-of-care coagulation systems (Cascade POC, ABRAZO, Actalyke).
• Helena BiosciencescoreTechnology or IntegrationDistribution partnership for Helena Biosciences diagnostic products including specialized reagents and kits for electrophoresis and clinical chemistry applications.
• Meridian BiosciencecoreTechnology or IntegrationDistribution partnership for Meridian Bioscience molecular diagnostics and microbiology products in Brazil, including tests for infectious diseases.
• CorgenixcoreTechnology or IntegrationDistribution partnership for Corgenix diagnostic products including specialized immunoassay tests and reagents.
• GenScriptcoreTechnology or IntegrationExclusive Brazilian distributor for GenScript's cPass SARS-CoV-2 Neutralization Antibody Detection Kit. GenScript is a leading biotechnology company and the world's most cited biotechnology company (52,500+ peer-reviewed articles as of December 2020). The cPass test was the world's first surrogate virus neutralization test for COVID-19.
• ViramedcoreTechnology or IntegrationExclusive Brazilian distributor for Viramed's ViraChip SARS-CoV-2 IgA/IgG microarray immunoblot test for differential detection of viral proteins S1, S2, and N.
• CellexcoreTechnology or IntegrationDistribution partnership for Cellex qSARS-CoV-2 IgG/IgM Rapid Test cassette. Product received FDA Emergency Use Authorization and ANVISA registration with 93.8% sensitivity and 96% specificity.
• HelixcoreTechnology or IntegrationDistribution partnership for Helix i-SARS-CoV-2 Ag Rapid Test for antigen detection in 15 minutes using nasopharyngeal, throat, or anterior nasal swab samples.
• AlltestcoreTechnology or IntegrationDistribution partnership for Alltest oral fluid rapid antigen test for COVID-19. Saliva-based testing with 90.1% sensitivity and 99.3% specificity, ANVISA registered.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Sebia: Sebia is a global leader in clinical electrophoresis and is the most direct competitor to NL Diagnóstica's V8 capillary electrophoresis and SPIFE gel electrophoresis systems. Both companies compete in protein, urine, and immunofixation testing instrumentation sold to clinical laboratories worldwide.
• Helena Laboratories: Helena Laboratories is the manufacturer of the V8, SPIFE, AggRAM, and Cascade product lines that NL Diagnóstica exclusively distributes in Brazil. As both a partner and competing IVD manufacturer in other markets, Helena Labs represents the closest product-line overlap for NL's flagship distributed portfolio.

Broad incumbents

• Sysmex Corporation: Sysmex is a global leader in hematology, coagulation, and platelet aggregation instrumentation — directly overlapping with NL Diagnóstica's AggRAM, PlateletWORKS, and Cascade product lines. Represents the kind of global IVD incumbent whose products could be distributed by or compete with NL.
• Hermes Pardini: Hermes Pardini is a major Brazilian diagnostic laboratory network and one of NL Diagnóstica's potential large-volume laboratory customers. Comparable Brazilian market presence in clinical diagnostics; both companies compete for recognition as trusted diagnostic brands in Brazil.
• Bio-Rad Laboratories: Bio-Rad is a global IVD manufacturer with products in clinical chemistry, immunology, and electrophoresis that compete directly with NL's distributed Helena Labs portfolio. Represents the broader competitive landscape that NL's international principals also face.
• Diagnósticos da América (DASA): DASA is the largest diagnostic laboratory chain in Brazil and a significant customer of IVD equipment manufacturers including NL Diagnóstica. While primarily a lab operator rather than equipment distributor, DASA represents the scale end of the Brazilian diagnostics market that defines NL's addressable customer base.

Regional players

• Laborclin: Laborclin is a Brazilian manufacturer and distributor of IVD reagents, clinical chemistry, and hematology products. Both companies serve Brazilian clinical laboratories with overlapping product categories including ELISA kits, rapid tests, and parasitology reagents.
• Gold Analisa Diagnóstica: Gold Analisa is a Brazilian IVD reagent manufacturer that competes head-to-head with NL Diagnóstica in clinical chemistry, ELISA, and rapid diagnostic tests sold to Brazilian clinical laboratories. Comparable product mix and customer base, focused exclusively on the Brazilian market.
• Doles Reagentes: Doles is a Brazilian IVD manufacturer specializing in hematology, clinical chemistry, and immunohematology reagents. Comparable Brazilian-focused IVD manufacturer serving the same clinical laboratory customer base as NL Diagnóstica.

Emerging players

• Mindray Bio-Medical: Mindray is a rapidly growing Chinese IVD manufacturer expanding aggressively in Latin America with clinical chemistry, hematology, and immunoassay analyzers. Represents the emerging competitive threat of low-cost IVD instrumentation targeting price-sensitive markets like Brazil.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Instagraminstagram.com/a1cbrasil
• Facebookfacebook.com/NLdiagnostica
• LinkedInlinkedin.com/company/nl-diagnostica

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NL Diagnóstica